Search research articles
Contact Us
Filters
Showing results (1-10 of 168) with videos related to
Page
of 17
Sort By:
Autoimmunity Reviews
|
February 22, 2012
Synthetic peptides as tools for diagnosis and therapeutic strategies to treat systemic lupus erythematous
Sylviane Muller
Autoimmunity Reviews
|
March 16, 2023
The abscopal effect: Implications for drug discovery in autoimmunity
Sylviane Muller
Swiss Medical Weekly
|
July 3, 2018
Excipients: not so inert? When the excipient plays the role of an active substance, as exemplified by systemic lupus
Sylviane Muller
Medecine Sciences : M/S
|
April 4, 2017
[Autophagy, autoimmunity and autoimmune diseases]
Sylviane Muller
Chemmedchem
|
July 22, 2015
Nanomaterials, Autophagy, and Lupus Disease
Alberto Bianco, Sylviane Muller
Frontiers in Immunology
|
June 5, 2015
Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target
Fengjuan Wang, Sylviane Muller
Autoimmunity Reviews
|
February 12, 2004
Peptide-based immunotherapy of systemic lupus erythematosus
Fanny Monneaux, Sylviane Muller
Arthritis Research & Therapy
|
July 14, 2009
Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects
Fanny Monneaux, Sylviane Muller
Nature Reviews. Nephrology
|
March 9, 2023
The role of lysosomes in metabolic and autoimmune diseases
Frédéric Gros, Sylviane Muller
Arthritis and Rheumatism
|
July 13, 2002
Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences
Fanny Monneaux, Sylviane Muller
Page
of 17
Search research articles
Search
Showing results (1-10 of 168) with videos related to
Sort By:
Page
of 17
Autoimmunity Reviews
|
February 22, 2012
Synthetic peptides as tools for diagnosis and therapeutic strategies to treat systemic lupus erythematous
Sylviane Muller
Autoimmunity Reviews
|
March 16, 2023
The abscopal effect: Implications for drug discovery in autoimmunity
Sylviane Muller
Swiss Medical Weekly
|
July 3, 2018
Excipients: not so inert? When the excipient plays the role of an active substance, as exemplified by systemic lupus
Sylviane Muller
Medecine Sciences : M/S
|
April 4, 2017
[Autophagy, autoimmunity and autoimmune diseases]
Sylviane Muller
Chemmedchem
|
July 22, 2015
Nanomaterials, Autophagy, and Lupus Disease
Alberto Bianco, Sylviane Muller
Frontiers in Immunology
|
June 5, 2015
Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target
Fengjuan Wang, Sylviane Muller
Autoimmunity Reviews
|
February 12, 2004
Peptide-based immunotherapy of systemic lupus erythematosus
Fanny Monneaux, Sylviane Muller
Arthritis Research & Therapy
|
July 14, 2009
Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects
Fanny Monneaux, Sylviane Muller
Nature Reviews. Nephrology
|
March 9, 2023
The role of lysosomes in metabolic and autoimmune diseases
Frédéric Gros, Sylviane Muller
Arthritis and Rheumatism
|
July 13, 2002
Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences
Fanny Monneaux, Sylviane Muller
Page
of 17